구리 IUD 시장 : 예측(2025-2030년)

The Copper IUD Market is expected to attain US$7.744 billion in 2030, growing at a CAGR of 5.17% during the forecast period from US$6.019 billion in 2025.

Copper intrauterine devices (IUDs) represent a significant advancement in hormone-free contraception, offering effective pregnancy prevention for up to ten years. The global copper IUD market is primarily driven by the increasing demand for non-hormonal contraceptive options, as more consumers seek alternatives that do not involve hormonal side effects. This growing preference is further supported by heightened consumer awareness regarding the benefits of copper IUDs, including their long-term efficacy and safety, which is expected to bolster demand throughout the forecast period.

Several factors are contributing to the growth of the copper IUD market. Firstly, the rising adoption of non-hormonal contraceptives is a key driver, as consumers increasingly prefer options that minimize potential hormonal side effects. Additionally, enhanced education and awareness about the effectiveness and safety of copper IUDs are anticipated to further stimulate demand in the coming years.

Geographically, the copper IUD market exhibits diverse growth patterns. In North America, demand is being fueled by advancements in healthcare and an increasing focus on contraceptive options. Europe is witnessing growth due to government initiatives aimed at raising consumer awareness about contraceptive choices. Meanwhile, in the Asia-Pacific region, urbanization and a rising consumer preference for effective, hormone-free contraceptives are propelling market expansion. In South America, the Middle East, and Africa, significant growth is expected as governments promote family planning awareness and seek efficient contraceptive solutions.

Overall, as awareness of and demand for non-hormonal contraceptive methods continue to grow, the copper IUD market is well-positioned for substantial expansion in the foreseeable future.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Copper IUD Market is analyzed into the following segments:

By End User

• Hospitals
• Gynecology Clinics
• Community Health Care Centers

By Distribution Channel

• Direct Sales
• Online Sales

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. COPPER IUDS MARKET BY END-USER

• 5.1. Introduction
• 5.2. Hospitals
• 5.3. Gynecology Clinics
• 5.4. Community Health Care Centers

6. COPPER IUDS MARKET BY DISTRIBUTION CHANNEL

• 6.1. Introduction
• 6.2. Direct Sales
• 6.3. Online Sales

7. COPPER IUDS MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. By End-User
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Country
    • 7.2.3.1. USA
    • 7.2.3.2. Canada
    • 7.2.3.3. Mexico
• 7.3. South America
  • 7.3.1. By End-User
  • 7.3.2. By Distribution Channel
  • 7.3.3. By Country
    • 7.3.3.1. Brazil
    • 7.3.3.2. Argentina
    • 7.3.3.3. Others
• 7.4. Europe
  • 7.4.1. By End-User
  • 7.4.2. By Distribution Channel
  • 7.4.3. By Country
    • 7.4.3.1. United Kingdom
    • 7.4.3.2. Germany
    • 7.4.3.3. France
    • 7.4.3.4. Spain
    • 7.4.3.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. By End-User
  • 7.5.2. By Distribution Channel
  • 7.5.3. By Country
    • 7.5.3.1. Saudi Arabia
    • 7.5.3.2. UAE
    • 7.5.3.3. Others
• 7.6. Asia Pacific
  • 7.6.1. By End-User
  • 7.6.2. By Distribution Channel
  • 7.6.3. By Country
    • 7.6.3.1. China
    • 7.6.3.2. Japan
    • 7.6.3.3. India
    • 7.6.3.4. South Korea
    • 7.6.3.5. Taiwan
    • 7.6.3.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Bayer (Pty) Ltd
• 9.2. Pregna International Limited
• 9.3. SMB Corporation
• 9.4. CooperSurgical, Inc
• 9.5. Mona Lisa N.V.
• 9.6. EurimPharm Arzneimittel GmbH

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key benefits for the stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations